XHKG0570
Market cap1.48bUSD
Dec 23, Last price
2.28HKD
1D
0.44%
1Q
-47.22%
Jan 2017
-36.49%
Name
China Traditional Chinese Medicine Holdings Co Ltd
Chart & Performance
Profile
China Traditional Chinese Medicine Holdings Co. Limited, an investment holding company, engages in the research and development, production, and sale of Chinese medicine and pharmaceutical products in the People's Republic of China. The company offers granules, finished drugs, decoction pieces, and healthcare products. It is also involved in the plantation and management of Chinese medicinal herbs; manufacturing of traditional Chinese medicines (TCM); trading of pharmaceutical products; provision of TCM marketing, advertising, and consulting services; and retail of pharmaceuticals and decoction products. The company also provides property leasing services. It sells its products to hospitals and retail pharmacies. The company was formerly known as China Traditional Chinese Medicine Co. Limited and changed its name to China Traditional Chinese Medicine Holdings Co. Limited in July 2016. China Traditional China Traditional Chinese Medicine Holdings Co. Limited was founded in 1573 and is headquartered in Wan Chai, Hong Kong.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 18,121,861 26.69% | 14,304,242 -24.92% | 19,052,802 28.68% | |||||||
Cost of revenue | 16,979,520 | 13,266,123 | 16,474,492 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 1,142,341 | 1,038,119 | 2,578,310 | |||||||
NOPBT Margin | 6.30% | 7.26% | 13.53% | |||||||
Operating Taxes | (171,537) | 119,357 | 396,856 | |||||||
Tax Rate | 11.50% | 15.39% | ||||||||
NOPAT | 1,313,878 | 918,762 | 2,181,454 | |||||||
Net income | 1,285,200 68.11% | 764,486 -60.45% | 1,932,858 16.21% | |||||||
Dividends | (240,000) | (314,427) | (275,779) | |||||||
Dividend yield | 1.21% | 1.76% | 1.06% | |||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 2,969,340 | 4,513,642 | 2,170,717 | |||||||
Long-term debt | 2,289,256 | 608,568 | 2,990,404 | |||||||
Deferred revenue | 421,291 | 437,839 | 390,695 | |||||||
Other long-term liabilities | ||||||||||
Net debt | 1,556,135 | 2,041,803 | 2,248,358 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 1,168,809 | 1,092,362 | 796,029 | |||||||
CAPEX | (483,925) | (527,273) | (877,198) | |||||||
Cash from investing activities | (477,620) | (374,153) | (536,936) | |||||||
Cash from financing activities | (584,306) | (557,279) | (724,316) | |||||||
FCF | 137,366 | (256,263) | (466,085) | |||||||
Balance | ||||||||||
Cash | 3,690,614 | 3,670,176 | 4,140,513 | |||||||
Long term investments | 11,847 | (589,769) | (1,227,750) | |||||||
Excess cash | 2,796,368 | 2,365,195 | 1,960,123 | |||||||
Stockholders' equity | 23,936,618 | 23,175,497 | 22,889,946 | |||||||
Invested Capital | 26,721,675 | 25,677,109 | 25,874,284 | |||||||
ROIC | 5.01% | 3.56% | 8.84% | |||||||
ROCE | 3.72% | 3.50% | 8.74% | |||||||
EV | ||||||||||
Common stock shares outstanding | 5,035,801 | 5,035,801 | 5,035,801 | |||||||
Price | 3.93 10.70% | 3.55 -31.33% | 5.17 40.49% | |||||||
Market cap | 19,790,698 10.70% | 17,877,094 -31.33% | 26,035,091 40.49% | |||||||
EV | 24,123,316 | 22,927,674 | 31,454,726 | |||||||
EBITDA | 2,275,612 | 2,137,516 | 3,427,907 | |||||||
EV/EBITDA | 10.60 | 10.73 | 9.18 | |||||||
Interest | 199,045 | 220,695 | 222,029 | |||||||
Interest/NOPBT | 17.42% | 21.26% | 8.61% |